About us

We develop and manufacture novel biologics and biosimilars for biotechnology companies around the planet, including for our own portfolio which we look to partner and out-licence.

We create quality biologics with passion from our three sites in Poland and the Netherlands, these are some of the most modern and largest facilities in Europe.

Our history

Our values

These are the values that we at Polpharma Biologics are guided by, help shape our decisions and drive us forward. We care about:

Creating quality biologics with passion

We are passionate about providing safe and effective medicines to patients.

We work with dedication and find innovative solutions.

We are self-motivated to reach the end result - “wait and see” is not in our vocabulary.

Delivering on our commitments

We are committed to positive outcomes and delivering projects on time, to specification.

We are experts in managing projects and communicate clearly and concisely.

We anticipate potential issues before they arise, always ensuring high quality outcomes.

Being respectful and transparent

We are open and honest without exception.

We value everyone equally and always treat others with respect.

We like to collaborate and can rely on each other.

What we do

Our mission is to create quality biologics with a passion to improve the lives of patients. We do this through two streams of business:

Novel biologics & biosimilar portfolio

We have our own pipeline of novel biologics & biosimilars which we partner or out-license. We are focused on advancing and expanding our product portfolio to increase patient access to these much-needed therapies.

Contract development and manufacturing

We have fully integrated solutions to support academic, small biotech and large pharma's biologic development projects from early stage discovery through to commercial supply.

Who we work with

Whether you are at an academic institution looking to get your idea off the ground or part of one of the worlds largest biotechnology companies, we have solutions to fit your needs, from pre-clinical to commercial.

Our sites

With state-of-the-art facilities across Europe, Polpharma Biologics is at the forefront of the next wave in biotechnology, leveraging our knowledge, capabilities and footprint to develop innovative solutions for the industry.

icon Gdańsk

Our Gdansk site includes mammalian and microbial R&D and manufacturing facilities for mid-scale production including drug product and fill finish.

icon Warsaw

Our Warsaw site is one of the largest biologics manufacturing sites in Europe, with capabilities for preclinical, clinical and commercial supply to EU and US standards.

icon Utrecht

Our Utrecht site is one of innovation and leads the discovery, optimization and development of novel biologics and biosimilars as well as being home to our industry leading cell line development platform.

Our sites

With state-of-the-art facilities across Europe, Polpharma Biologics is at the forefront of the next wave in biotechnology, leveraging our knowledge, capabilities and footprint to develop innovative solutions for the industry.

  • Gdańsk
  • Warsaw
  • Utrecht
  • Our Gdansk site includes mammalian and microbial R&D and manufacturing facilities for mid-scale production including drug product and fill finish.

  • Our Warsaw site is one of the largest biologics manufacturing sites in Europe, with capabilities for preclinical, clinical and commercial supply to EU and US standards.

  • Our Utrecht site is one of innovation and leads the discovery, optimization and development of novel biologics and biosimilars as well as being home to our industry leading cell line development platform.

Innovation in Poland

Over the last decade Polpharma Biologics has created a biotechnology sector almost from scratch in Poland. We consistently invest, not only laboratories and production lines, but also in know-how, driving growth of highly-qualified jobs, as well as developing cooperation between science and business.

Our team

At Polpharma Biologics, our commitment to excellence begins at the top. With decades of combined experience in the development, manufacture and commercialization of biopharmaceuticals. Our international management team brings both knowledge and passion to every project.

"It is here that new molecules, active substances and drugs for the largest companies in the world are created"

Next
Jerzy Starak

Chairman, Polpharma Biologics Group

“We care about delivering on our commitments”

Next
Hannes Teissl

Vice Chairman, Polpharma Biologics Group

“We are passionate about getting safe and effective medicines to patients”

Next
Dr Joerg Windisch

President & CEO, Polpharma Biologics Group

"We care about delivering on our commitments"

Next
Jan Krzewiński

President, Polpharma Biologics Gdańsk

“We work with dedication and find innovative solutions”

Next
Frederic Papp

President, Polpharma Biologics Warsaw

Let’s collaborate and create quality biologics together.

Get in touch for more information.